News
Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...
Medpage Today on MSN23h
Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New DataTORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback